Analysts expect over 2018 rising revenue Johnson & Johnson

Tomorrow the American Johnson & Johnson will report its past quarter's results. Over the current book year the total revenue will be 81,23 billion USD (consensus estimates). This is slightly more than 2017's revenue of 76,45 billion USD.

Historical revenues and results Johnson & Johnson plus estimates 2018

financial analysis

The analysts expect for 2018 a net profit of 22,18 billion USD. For this year the consensus of the result per share is a profit of 8,15 USD. Based on this the price/earnings-ratio is 16,43.

Per share the analysts are expecting a dividend of 3,57 USD per share. Thus the dividend yield equals 2,67 percent. The average dividend yield of the health care companies is a limited 1 percent.

Newest target prices around 144 USD

The most recent recommendations for the health care company are from Morgan Stanley , Jefferies & Co. and KBC Securities.

Johnson & Johnson 's market capitalization is based on the number of outstanding shares around 362,32 billion USD. The Johnson & Johnson stock was the past 12 months quite volatile. Since last October the stock is 1 percent higher. This year the stock price moved between 119 and 148 dollar. Since 2008 the stock price is almost 121 percent higher.

On Friday the stock closed at 133,87 USD.

Historical stock prices Johnson & Johnson

financial analysis johnson&johnson

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.